| Literature DB >> 27152441 |
Tristan McCaughey1, Paul G Sanfilippo2, George E C Gooden3, David M Budden4, Li Fan5, Eva Fenwick2, Gwyneth Rees2, Casimir MacGregor6, Lei Si7, Christine Chen1, Helena Hai Liang2, Timothy Baldwin8, Alice Pébay9, Alex W Hewitt10.
Abstract
Ongoing breakthroughs with CRISPR/Cas-based editing could potentially revolutionize modern medicine, but there are many questions to resolve about the ethical implications for its therapeutic application. We conducted a worldwide online survey of over 12,000 people recruited via social media to gauge attitudes toward this technology and discuss our findings here.Entities:
Mesh:
Year: 2016 PMID: 27152441 DOI: 10.1016/j.stem.2016.04.011
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633